Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn.

Christou, H; Magnani, B; Morse, D S; Allred, E N; Van Marter, L J; Wessel, D L; Kourembanas, S

Christou, H; Magnani, B; Morse, D S; Allred, E N; Van Marter, L J; Wessel, D L; Kourembanas, S.

Affiliation

Christou H; Division of Newborn Medicine, Children's Hospital, Boston, MA 02115, USA.

Pediatrics ; 102(6): 1390-3, 1998 Dec.

Article in En | MEDLINE | ID: mdl-9832574

Subject(s)

Nitric Oxide/pharmacology; Persistent Fetal Circulation Syndrome/physiopathology; Platelet Activation/drug effects; Adenosine Diphosphate/physiology; Flow Cytometry; Humans; Infant, Newborn; Nitric Oxide/therapeutic use; P-Selectin/blood; Persistent Fetal Circulation Syndrome/blood; Persistent Fetal Circulation Syndrome/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Persistent Fetal Circulation Syndrome / Platelet Activation / Nitric Oxide Type of study: Clinical_trials Limits: Humans / Newborn Language: En Journal: Pediatrics Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links